2018 Constipation Drug Development- Pipeline Analysis Report

May 2018 | | ID: 2FD13014BAAEN
VPAResearch

Abstracts

With an estimated $20 billion market value, the Constipation is one of the most common gastrointestinal conditions, presenting robust opportunities for development of treatment options. In addition to hard bowel moment, other symptoms of Constipation include bloating and abdominal pain.

Over 50 companies and universities are focusing on developing treatment options for Constipation.

To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Constipation pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Constipation pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Constipation pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 CONSTIPATION PIPELINE ANALYSIS

2.1 Disease and Pipeline Overview
2.2 Constipation Pipeline Snapshot
2.3 Constipation Pipeline by Phase
2.4 Constipation Pipeline by Company
2.5 Constipation Pipeline by Mechanism of Action

3 CONSTIPATION- COMPANY WISE PIPELINE ANALYSIS

Ache Laboratories
Allergan
Ardelyx Inc
BioGaia
Braintree Laboratories
Braintree Laboratories Inc
Dong-A ST Co Ltd
EA Pharma Co Ltd
Enterin Inc
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals Inc
Mallinckrodt
NGM Biopharmaceuticals
Nordic Life Science Pipeline
RaQualia Pharma
Renexxion LLC
Shire-Movetis N.V.
SK Biopharmaceuticals
Sumitomo Dainippon Pharma Co Ltd
Synergy Pharmaceuticals
Synthetic Biologics
Tsumura
Vanda Pharmaceuticals
Yuhan

4 CONSTIPATION R&D PIPELINE SNAPSHOTS

Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details

5 RECENT DEVELOPMENTS IN CONSTIPATION PIPELINE

6 APPENDIX

6.1 About VPA Research
6.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Constipation Pipeline by Phase, H1- 2018
Figure 2: Constipation Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Constipation Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018

List Of Tables

LIST OF TABLES

Table 1: Constipation Pipeline by Phase, H1- 2018
Table 2: Constipation Pipeline by Companies, H1- 2018
Table 3: Constipation Pipeline by Mechanism of Action, H1- 2018
Table 4: Ache Laboratories Constipation pipeline, May 2018
Table 5: Allergan Constipation pipeline, May 2018
Table 6: Ardelyx Inc Constipation pipeline, May 2018
Table 7: BioGaia Constipation pipeline, May 2018
Table 8: Braintree Laboratories Constipation pipeline, May 2018
Table 9: Braintree Laboratories Inc Constipation pipeline, May 2018
Table 10: Dong-A ST Co Ltd Constipation pipeline, May 2018
Table 11: EA Pharma Co Ltd Constipation pipeline, May 2018
Table 12: Enterin Inc Constipation pipeline, May 2018
Table 13: Ironwood Pharmaceuticals Constipation pipeline, May 2018
Table 14: Ironwood Pharmaceuticals Inc Constipation pipeline, May 2018
Table 15: Mallinckrodt Constipation pipeline, May 2018
Table 16: NGM Biopharmaceuticals Constipation pipeline, May 2018
Table 17: Nordic Life Science Pipeline Constipation pipeline, May 2018
Table 18: RaQualia Pharma Constipation pipeline, May 2018
Table 19: Renexxion LLC Constipation pipeline, May 2018
Table 20: Shire-Movetis N.V. Constipation pipeline, May 2018
Table 21: SK Biopharmaceuticals Constipation pipeline, May 2018
Table 22: Sumitomo Dainippon Pharma Co Ltd Constipation pipeline, May 2018
Table 23: Synergy Pharmaceuticals Constipation pipeline, May 2018
Table 24: Synthetic Biologics Constipation pipeline, May 2018
Table 25: Tsumura Constipation pipeline, May 2018
Table 26: Vanda Pharmaceuticals Constipation pipeline, May 2018
Table 27: Yuhan Constipation pipeline, May 2018